BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,092 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $9,516,000 | -35.6% | 118,600 | -35.4% | 1.57% | -48.4% |
| Q3 2020 | $14,765,000 | -4.8% | 183,600 | +1.9% | 3.04% | -17.0% |
| Q2 2020 | $15,507,000 | +8.1% | 180,100 | +1.9% | 3.66% | -9.3% |
| Q1 2020 | $14,346,000 | -7.6% | 176,700 | -4.8% | 4.04% | +16.5% |
| Q4 2019 | $15,528,000 | -8.4% | 185,700 | -4.1% | 3.47% | -19.4% |
| Q3 2019 | $16,943,000 | +6.8% | 193,700 | 0.0% | 4.30% | +17.4% |
| Q2 2019 | $15,864,000 | -1.5% | 193,700 | -2.2% | 3.66% | +12.6% |
| Q1 2019 | $16,099,000 | +26.7% | 198,000 | +2.6% | 3.26% | +19.2% |
| Q4 2018 | $12,704,000 | -11.4% | 193,000 | +3.8% | 2.73% | +9.9% |
| Q3 2018 | $14,339,000 | +9.2% | 186,000 | +4.6% | 2.48% | +0.9% |
| Q2 2018 | $13,133,000 | – | 177,861 | – | 2.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |